» Download Public Reports
23 reports
- Company report
- March 2011
- 5 pages
... India's largest drug manufactus by market value and engages with specialty medicine and apis for chronic therapy areas such as cardiology, psychiatry, neurology, etc. Company has forayed into regulated ...
March 2011
... And has developed expertise in three therapeutic fields: anti-infectives, pain/inflammation and cardiology/nephrology. The group currently distributes its products in more than one hundred countries ...
March 2011
... To a significant increase in our revenues for the first quarter of 2012. We will continue to carefully monitor our expenses and ensure the best strategic use of our cash as we transform nicox into an ophthalmology ...
March 2011
... Clinical research and molecular imaging gastroenterology pulmonology urology intensive care robotic surgery 25 trained sales professionals dedicated to 3 priority development markets strictly personal ...
July 2011
... Of 2010, with 487,000 stays. The increase was driven by surgery (+3.7%), With obstetrics stable and general medicine edging down (-0.8%). In the public-service missions managed by the group, the number ...
March 2013
... Guerbet is the only pharmaceutical group fully dedicated to medical imaging worldwide. As such it has a complete offering of contrast products for x-ray and mri and for interventional radiology, along ...
April 2012
... In psychology graduate school ryan woodfield, pharmacy as pre-science pharmd 2014 cvs pharmacy intern graduates and future plans samantha fordyce, optometry bs vision therapy doctor of optometry 2015 ...
March 2012
... In the oesophagus, the odm technology precisely measures 10% changes in stroke volume, enabling clinicians to effectively intervene early during surgery, and control the management of fl uid. Randomised ...
May 2011
... Medical approach seeing the aim of dentistry in treating or preventing pain and preserving tooth substance. Guests and hosts agreed that new dental materials have to consider both demands. According ...
» Purchase Premium Reports
(From $ 125 - $ 3 995)
49 reports
- $ 3 995
- Industry report
- April 2013
- by Global Data
EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022 Summary Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrosing interstitial pneumonia of unknown cause that occurs primarily ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
April 2013
$ 125
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
